Milestone Pharmaceuticals Inc. ( MIST) - Stock Earnings
MIST Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026 BeforeMarket | -0.21 / — | — | 560000 / — | — |
MIST Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -17.4 million USD | 1.5 million USD |
| 2026Q1 | -26.1 million USD | 238000 USD |
| 2026Q2 | -28.6 million USD | 559000 USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
MIST Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.7 million USD | 1.0 million USD |
| 2024 | -41.5 million USD | — USD |
| 2025 | -63.1 million USD | 1.5 million USD |
| 2026 Est. | — | — |
MIST
Price: $1.10
52 week price:
Earnings Per Share: -0.65 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 563278
Market Capitalization: 136.9 million